Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vaxcyte Inc
PCVXCurrent price
107.29 USD
+0.92 USD (+0.86%)
Last closed
106.35 USD
Company
vaxcyte.com
ISIN
US92243G1085
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
13 980 052 480 USD
Yield for 12 month
+111.41 %
1Y
3Y
5Y
10Y
15Y
PCVX
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California. Address: 825 Industrial Road, San Carlos, CA, United States, 94070
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
149.29 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-75 000 000 USD
Last Year
-9 196 000 USD
Current Quarter
-3 478 000 USD
Last Quarter
-3 091 000 USD
Key Figures PCVX
1 year
3 years
5 years
10 years
EBITDA
-573 110 976 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-20.1 %
PEG Ratio
–
Return On Equity TTM
-29.08 %
Wall Street Target Price
149.29 USD
Revenue TTM
–
Book Value
17.96 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-22 995 000 USD
Earnings per share
-4.69 USD
Diluted Eps TTM
-4.69 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics PCVX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PCVX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation PCVX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-14.4283
Price Book MRQ
7.0388
Financials PCVX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PCVX
For 52 weeks
46.16 USD
121.06 USD
50 Day MA
106.05 USD
Shares Short Prior Month
9 651 135
200 Day MA
80.01 USD
Short Ratio
12.28
Shares Short
9 344 117
Short Percent
8.58 %
BeatStart